Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infections in children under two years old, resulting in significant morbidity and a heavy economic burden on healthcare ...

Shionogi’s respiratory syncytial virus (RSV) antiviral for adults has proven its ability to reduce viral load in a phase 2 ...

Research reveals that even low levels of air pollution significantly increase the risk of respiratory infections in adults, ...

In the throes of winter's yearly round of respiratory virus outbreaks, it pays to remember what Grandma told you.

Seven-year-old Harmony from Sheffield is supporting The Children’s Hospital Charity by taking part in Theo’s Pyjama Day in ...

North Carolina reports a spike in flu cases and 117 deaths, urging the public to get vaccinated and seek early treatment.

Nirsevimab is protective against RSV infections and coinfections, which suggests there is no replacement of RSV with other viruses post-nirsevimab administration.

Many nursing home residents are refusing COVID shots this winter, though flu vaccine penetration has remained strong historically.

“Watched my baby with a tube down his throat for eight days and wasn’t sure if I was ever going to hold him again,” Elliot’s ...

Respiratory syncytial virus (RSV) is the most important cause of infantile bronchiolitis and pneumonia. It is ubiquitous, with most children acquiring their primary infection within the first year ...